The novel treatment of the medication represents a major advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – providing greater sugar control and anticipated weight loss. Researchers are investigatin